News
BHC
--
0.00%
--
Statement from the Chief Public Health Officer of Canada on January 16, 2021
CNW Group · 2d ago
Bausch Health remains a buy at Truist on management remarks
Truist Securities reiterates its buy rating on Bausch Health (BHC) on management comments made at the ongoing J.P. Morgan Healthcare Conference particularly regarding the strategic alternatives being considered by the
Seekingalpha · 5d ago
What to watch today: Stocks set for modest drop
U.S. stock futures fell Wednesday, a day after Wall Street resumed its 2021 upswing with modest gains.
CNBC.com · 5d ago
Stocks making the biggest moves in the premarket: Urban Outfitters, Target, KB Home & more
The stocks making the biggest moves in premarket trading include Urban Outfitters, Target, KB Home, and more.
CNBC.com · 5d ago
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12)
Benzinga · 5d ago
Bausch Health sees FY20 revenue to exceed higher end of previous guidance
Bausch Health (BHC) expects its Q4 revenue to be greater than $2.20B vs. consensus of $2.12B.FY20 to exceed the high end of its latest revenue guidance range of $7.80 – $8B vs. consensus of
Seekingalpha · 6d ago
Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery
, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will provide a preliminary update on its fourth-quarter and full-year 2020 financial results and the continued pace of its business recovery from the COVID-1...
PR Newswire - PRF · 6d ago
Bausch Health Provides Preliminary Update On Fourth-Quarter And Full-Year 2020 Financial Results And Business Recovery
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") will provide a preliminary update on its fourth-quarter and full-year 2020 financial results and the continued pace of its business recovery from the COVID-19 pandemic tomorrow...
PR Newswire · 6d ago
Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference
LAVAL, QC, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that , chairman and chief executive officer, is scheduled to participate at the 39 Annual J.P. Morgan Healthcare Conference on at .
PR Newswire - PRF · 01/06 12:00
Bausch Health To Participate At The 39th Annual J.P. Morgan Healthcare Conference
PR Newswire · 01/06 12:00
Who Has Been Buying Bausch Health Companies Inc. (NYSE:BHC) Shares?
Simply Wall St. · 01/03 06:54
More drugs see price hikes yet at a lower rate than last year
As details on the newly implemented drug price hike pour in, the analysts point to a higher number of drugs becoming more expensive this year, yet at a less sharp
Seekingalpha · 01/03 05:16
Glenview Capital's Larry Robbins reveals top 10 picks for 2021
Larry Robbins, Founder and CEO of Glenview Capital Management, picks his top 10 stocks for 2021.Glenview Capital's 13F portfolio reported a value decline of $22B in the past five years.At
Seekingalpha · 12/31/2020 17:05
Larry Robbins hedge fund indicates top fund holdings as 2021 picks, a mixed pack
Larry Robbins, Founder and CEO of Glenview Capital Management picks top 10 stock. Glenview Capital 13F portfolio reported a value decline of $22B in the past five years.At the end of
Seekingalpha · 12/31/2020 17:05
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)
LAVAL, QC, /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in has granted an additional new indication for DEXAV...
PR Newswire - PRF · 12/30/2020 12:00
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19)
PR Newswire · 12/30/2020 12:00
Stocks making the biggest moves premarket: Boeing, SAP, Lemonade, Alibaba & more
These are the stocks posting the largest moves before the bell.
CNBC.com · 12/29/2020 13:32
Bausch Health to cut debt by $275M
On Dec. 31, 2020, Bausch Health (BHC) will pay down an additional $275M of its senior secured term loans using cash on hand and cash generated from operations.Following this repayment,
Seekingalpha · 12/29/2020 12:14
Bausch Health to repay another $275 million of senior secured term loans
Bausch Health Cos. Inc. undefined said Tuesday it is planning to pay down another $275 million of senior secured term loans, using cash on hand and cash...
MarketWatch · 12/29/2020 12:10
Bausch Health To Pay Down Additional $275M Of Senior Secured Term Loans Using Cash On Hand And Cash from Operations
No Debt Maturities or Mandatory Amortization Payments Will Be Due Until 2024 Bausch Health Will Repay Approximately $900 Million of Debt in 2020 LAVAL, QC, Dec. 29, 2020 /PRNewswire/ -- Bausch
Benzinga · 12/29/2020 12:05
Webull provides a variety of real-time BHC stock news. You can receive the latest news about Bausch Health Companies Inc through multiple platforms. This information may help you make smarter investment decisions.
About BHC
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
More